Alcami, a provider of custom development and manufacturing services, has strengthened capabilities in analytical services at its site in Edison, New Jersey. Alcami’s laboratories in Edison offer chemistry, environmental and…
Xellia Pharmaceuticals, a specialty pharmaceutical company focused on anti-infectives, has expanded its product and innovation research and development (R&D) team with more than 15 scientists and has added approximately 1,000…
Merck KGaA To Invest More Than $55 Million in Packaging Expansion
Merck KGaA plans to invest more than EUR 50 million ($56 million) in a packaging building at its pharmaceutical manufacturing site in Darmstadt, Germany. The Darmstadt site is the company’s largest site…
Moderna to Build mRNA Clinical Manufacturing Facility
Moderna Therapeutics, a Cambridge, Massachusetts-based biotechnology company focusing on messenger RNA (mRNA) therapeutics, has signed a long-term lease to build a GMP clinical manufacturing facility in Norwood, Massachusetts. Moderna will…
Allergan Makes Second NASH Buy with Akarna Therapeutics
Allergan has acquired Akarna Therapeutics, a San Diego-based biopharmaceutical company focused on small-molecule therapeutics for inflammatory and fibrotic diseases, for an up-front payment of $50 million. The deal is subject…
Facebook Founder Commits $3 Billion to Fight Disease
Mark Zuckerberg, founder and chief executive officer of the social media website, Facebook, and his wife, Priscilla Chan, have pledged to invest $3 billion over the next decade in an…
WuXi Biologics Opens New Manufacturing Facility in China
WuXi Biologics, part of WuXi AppTec, a contract service provider, has opened a new commercial-scale cGMP biologics perfusion manufacturing facility in Wuxi City, China. The company announced plans to build…
GE To Invest in New Modular BioManufacturing Campus
GE has announced that it will invest EUR 150 million ($168 million) in a new biopharmaceutical manufacturing campus on Industrial Development Agency Ireland’s site at Loughbeg, Ringaskiddy, County Cork, Ireland. The…
UCB, a Brussels, Belgium-based biopharmaceutical company, has received approval from the US Food and Drug Administration for Briviact (brivaracetam) as an adjunctive therapy for treating the partial-onset of seizures in…
Teva, Regeneron Form $1.25 Billion Pain Therapy Pact
Teva Pharmaceutical Industries has formed a collaboration with Regeneron Pharmaceuticals, based in Tarrytown, New York, to develop and commercialize fasinumab, Regeneron’s investigational nerve growth factor (NGF) antibody in Phase III…